arXiv (All)
open access
From Benchmark to Bench: Can Agents Survive Real-World Drug Discovery?
Agentic systems increasingly coordinate molecular-design tools, but it is unclear which layer of the stack limits outcomes on real projects. We developed MAGI, an open modular agent that authors objectives, launches and monitors optimization, interprets structure--activity relationships, and revises
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Agentic BAIM-LLM Evaluation (ABLE): Benchmarking LLM Use of Protein Design Tools#973443
- MolDesignBench: Evaluating LLM-based Agent for Scenario-grounded Molecular Design#1063560
- TopoLIA: Topology-Inspired Latent Interaction Attention for Drug Discovery#1297358
- Autonomous Chemical Mechanistic Discovery through Agentic Reasoning and Validation#998699
- Lab to codes: multimodel advanced AI-driven pipelines to drive antimicrobial peptide design for the post-antibiotic era.#1346408
Record · ID 1215514
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive